|
[1]THAKER AM, MOSKO JD, BERZIN TM.Post-endoscopic retrograde cholangiopancreatography pancreatitis[J].Gastroenterol Rep (Oxf) , 2015, 3 (1) :32-40.
|
|
[2]DING X, ZHANG F, WANG Y.Risk factors for post-ERCP pancreatitis:A systematic review and meta-analysis[J].Surgeon, 2015, 13 (4) :218-229.
|
|
[3]DUMONCEAU JM, ANDRIULLI A, ELMUNZER BJ, et al.Prophylaxis of post-ERCP pancreatitis:European Society of Gastrointestinal Endoscopy (ESGE) guideline-updated June2014[J].Endoscopy, 2014, 46 (9) :799-815.
|
|
[4]HASHIMOTO S, ITO K, KOSHIDA S, et al.Risk factors for post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis and stent dysfunction after preoperative biliary drainage in patients with malignant biliary stricture[J].Intern Med, 2016, 55 (18) :2529-2536.
|
|
[5]FUJISAWA T, KAGAWA K, HISATOMI K, et al.Obesity with abundant subcutaneous adipose tissue increases the risk of postERCP pancreatitis[J].J Gastroenterol, 2016, 51 (9) , 931-938.
|
|
[6]EL NAKEEB A, EL HANAFY E, SALAH T, et al.Post-endoscopic retrograde cholangiopancreatography pancreatitis:risk factors and predictors of severity[J].World J Gastrointest Endosc, 2016, 8 (19) :709-715.
|
|
[7]KOKSAL AR, BOGA S, ALKIM H, et al.Chemerin:a new biomarker to predict postendoscopic retrograde cholangiopancreatography pancreatitis[J].Eur J Gastroenterol Hepatol, 2016, 28 (6) :714-721.
|
|
[8]INAMDAR S, BERZIN TM, SEJPAL DV, et al.Pregnancy is a risk factor for pancreatitis after endoscopic retrograde cholangiopancreatography in a National Cohort Study[J].Clin Gastroenterol Hepatol, 2016, 14 (1) :107-114.
|
|
[9]LEERHOY B, NORDHOLM-CARSTENSEN A, NOVOVIC S, et al.Effect of body weight on fixed dose of diclofenac for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis[J].Scand J Gastroenterol, 2016, 51 (8) :1007-1012.
|
|
[10]FINKELMEIER F, TAL A, AJOUAOU M, et al.ERCP in elderly patients:increased risk of sedation adverse events but low frequency of post-ERCP pancreatitis[J].Gastrointest Endosc, 2015, 82 (6) :1051-1059.
|
|
[11]PHILLIP V, SCHWAB M, HAF D, et al.Identification of risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis in a high volume center[J].PLo S One, 2017, 12 (5) :e0177874.
|
|
[12]TROENDLE DM, ABRAHAM O, HUANG R, et al.Factors associated with post-ERCP pancreatitis and the effect of pancreatic duct stenting in a pediatric population[J].Gastrointest Endosc, 2015, 81 (6) :1408-1416.
|
|
[13]MATSUBARA H, URANO F, KINOSHITA Y, et al.Analysis of the risk factors for severity in post endoscopic retrograde cholangiopancreatography pancreatitis:The indication of prophylactic treatments[J].World J Gastrointest Endosc, 2017, 9 (4) :189-195.
|
|
[14]HAYASHI S, NISHIDA T, SHIMAKOSHI H, et al.Combination of two-hour post-endoscopic retrograde cholangiopancreatography amylase levels and cannulation times is useful for predicting postendoscopic retrograde cholangiopancreatography pancreatitis[J].World J Gastrointest Endosc, 2016, 8 (20) :777-784.
|
|
[15]TRYLISKYY Y, BRYCE GJ.Role of heart rate variability in predicting post-endoscopic retrograde cholangiopancreatography pancreatitis[J].Acta Gastroenterol Belg, 2016, 79 (3) :429-434.
|
|
[16]PAPACHRISTOS A, HOWARD T, THOMSON BN, et al.Predicting post-endoscopic retrograde cholangiopancreatography pancreatitis using the 4-h serum lipase level[J].ANZ J Surg, 2018, 88 (1-2) :82-86.
|
|
[17]ZHANG FB, ZHU B, LIU W, et al.The clinical effect of octreotide combined with indomethacin on pancreatitis and hyperamylasemia after ERCP[J].Chin J Med Offic, 2015, 43 (7) :752-753, 755. (in Chinese) 章福彬, 朱斌, 刘卫, 等.奥曲肽联合吲哚美辛栓剂预防ERCP术后胰腺炎和高淀粉酶血症的临床研究[J].临床军医杂志, 2015, 43 (7) :752-753, 755.
|
|
[18]WAN J, REN Y, ZHU Z, et al.How to select patients and timing for rectal indomethacin to prevent post-ERCP pancreatitis:a systematic review and meta-analysis[J].BMC Gastroenterol, 2017, 17 (1) :43.
|
|
[19]SHEN C, SHI Y, LIANG T, et al.Rectal NSAIDs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in unselected patients:systematic review and meta-analysis[J].Dig Endosc, 2017, 29 (3) :281-290.
|
|
[20]MOHAMMAD ALIZADEH AH, ABBASINAZARI M, HATAMI B, et al.Comparison of rectal indomethacin, diclofenac, and naproxen for the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis[J].Eur J Gastroenterol Hepatol, 2017, 29 (3) :349-354.
|
|
[21]YANG C, ZHAO Y, LI W, et al.Rectal nonsteroidal anti-inflammatory drugs administration is effective for the prevention of postERCP pancreatitis:an updated meta-analysis of randomized controlled trials[J].Pancreatology, 2017, 17 (5) :681-688.
|
|
[22]FUJITA Y, HASEGAWA S, KATO Y, et al.Intravenous injection of low-dose flurbiprofenaxetil for preventing post-ERCP pancreatitis in high-risk patients:an interim analysis of the trial[J].Endosc Int Open, 2016, 4 (10) :e1078-e1082.
|
|
[23]HU J, LI PL, ZHANG T, et al.Role of Somatostatin in preventing post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis:an update meta-analysis[J].Front Pharmacol, 2016, 7:489.
|
|
[24]YUHARA H, OGAWA M, KAWAGUCHI Y, et al.Pharmacologic prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis:protease inhibitors and NSAIDs in a meta-analysis[J].J Gastroenterol, 2014, 49 (3) :388-399.
|
|
[25]YU G, LI S, WAN R, et al.Nafamostatmesilate for prevention of post-ERCP pancreatitis:a meta-analysis of prospective, randomized, controlled trials[J].Pancreas, 2015, 44 (4) :561-569.
|
|
[26]KIM SJ, KANG DH, KIM HW, et al.A randomized comparative study of 24-and 6-hour infusion of nafamostatmesilate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis:a prospective randomized comparison trial[J].Pancreas, 2016, 45 (8) :1179-1183.
|
|
[27]WU D, WAN J, XIA L, et al.The efficiency of aggressive hydration with lactated ringer solution for the prevention of Post-ERCP pancreatitis:a systematic review and meta-analysis[J].J Clin Gastroenterol, 2017, 51 (8) :e68-e76.
|
|
[28]WANG C, LI Q, YE P, et al.Value of raw rhubarb solution in the precaution of post-endoscopic retrograde cholangiopancreatography pancreatitis in patients with high-risk factors:a predictive random compared research in one center[J].Dig Dis Sci, 2017, 62 (4) :1043-1050.
|
|
[29]HAUSER G, BLAZEVIC I, SALKIC N, et al.Diclofenac sodium versus ceftazidime for preventing pancreatitis after endoscopic retrograde cholangiopancreatography:a prospective, randomized, controlled trial[J].Surg Endosc, 2017, 31 (2) :602-610.
|
|
[30]GOOSHE M, ABDOLGHAFFARI AH, NIKFAR S, et al.Antioxidant therapy in acute, chronic and post-endoscopic retrograde cholangiopancreatography pancreatitis:an updated systematic review and meta-analysis[J].World J Gastroenterol, 2015, 21 (30) :9189-9208.
|
|
[31]VADALA di PRAMPERO SF, FALESCHINI G, PANIC N, et al.Endoscopic and pharmacological treatment for prophylaxis against postendoscopic retrograde cholangiopancreatography pancreatitis:a meta-analysis and systematic review[J].Eur J Gastroenterol Hepatol, 2016, 28 (12) :1415-1424.
|
|
[32]de MOURA ET, de MOURA EG, BERNARDO W, et al.Guide wirea sistedcannulation versus conventional contrast to prevent pancreatitis.A systematic review and meta-analysis based on randomized control trials[J].Rev Gastroenterol Peru, 2016, 36 (4) :308-319.
|
|
[33]BUXBAUM J, LEONOR P, TUNG J, et al.Randomized trial of endoscopist-controlled vs.assistant-controlled wire-guided cannulation of the bile duct[J].Am J Gastroenterol, 2016, 111 (12) :1841-1847.
|
|
[34]SAKAI Y, TSUYUGUCHI T, SUGIYAMA H, et al.Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis by pancreatic duct stenting using a loop-tipped guidewire[J].World J Clin Cases, 2016, 4 (8) :213-218.
|
|
[35]TSE F, YUAN Y, MOAYYEDI P, et al.Double-guidewire technique in difficult biliary cannulation for the prevention of post-ERCP pancreatitis:a systematic review and meta-analysis[J].Endoscopy, 2017, 49 (1) :15-26.
|
|
[36]LI P, LU Y, ZHANG Y, et al.Effective application of Precut technique in patients with difficult ERCP intubation[J].J Clin Exp Med, 2017, 16 (21) :2144-2147. (in Chinese) 李攀, 卢媛, 张彦, 等.Precut技术在ERCP插管困难患者中的有效应用[J].临床和实验医学杂志, 2017, 16 (21) :2144-2147.
|
|
[37]MARIANI A, di LEO M, GIARDULLO N, et al.Early precut sphincterotomy for difficult biliary access to reduce post-ERCP pancreatitis:a randomized trial[J].Endoscopy, 2016, 48 (6) :530-535.
|
|
[38]ANG TL, KWEK AB, SONG M, et al.Comparative study of strategies for preventing post-ERCP pancreatitis after early precut sphincterotomy for biliary access[J].J Dig Dis, 2016, 17 (10) :692-696.
|
|
[39]ZAGALSKY D, GUIDI MA, CURVALE C, et al.Early precut is as efficient as pancreatic stent in preventing post-ERCP pancreatitis in high-risk subjects-A randomized study[J].Rev Esp Enferm Dig, 2016, 108 (9) :258-562.
|
|
[40]FUJISAWA T, KAGAWA K, HISATOMI K, et al.Is endoscopic papillary balloon dilatation really a risk factor for post-ERCP pancreatitis?[J].World J Gastroenterol, 2016, 22 (26) :5909-5916.
|
DownLoad: